Acute Myeloblastic Leukemia with Maturation

Search Trials
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
May 17, 2016
First Changed:
Apr 12, 2012
Disease(s):
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
Intervention(s):
laboratory biomarker analysisquizartinibsorafenib tosylate
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Status:
Completed
Last Changed:
Jan 28, 2022
First Changed:
Aug 29, 2006
Disease(s):
Childhood Acute Basophilic Leukemia
Intervention(s):
asparaginasedaunorubicin hydrochloridecytarabinethioguanineetoposidelaboratory biomarker analysis
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
Status:
Completed
Last Changed:
May 3, 2013
First Changed:
Jul 27, 2006
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
vorinostatcytarabineetoposidepharmacological studylaboratory biomarker analysis
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Status:
Completed
Last Changed:
May 6, 2010
First Changed:
Feb 17, 2006
Disease(s):
Chronic Myeloproliferative Disorders
Intervention(s):
clofarabinecyclophosphamide

Connect. Empower. Inspire.